Anti-Retinoic Acid Receptor alpha antibody (ab85058)

Overview

• Product nameAnti-Retinoic Acid Receptor alpha antibodySee all Retinoic Acid Receptor alpha primary antibodies ...
• Description
  Rabbit polyclonal to Retinoic Acid Receptor alpha
• Tested applicationsELISA, WB, IHC-P more details
• Species reactivity
  Reacts with: Mouse, Rat, Human
  
• Immunogen

  15 amino acids synthetic peptide from the C terminal region of Human Retinoic Acid Receptor alpha

• Positive controlHuman fetal brain lysate.

Properties

• FormLiquid
• Storage instructionsShipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.
• Storage bufferPreservative: 0.02% Sodium Azide
  Constituents: 0.5% BSA
• Concentration information loading...
• PurityImmunogen affinity purified
• Clonality Polyclonal
• IsotypeIgG
• Research Areas
  • Cancer
  • Signal transduction
  • Nuclear signaling
  • Nuclear hormone receptors
  • Retanoic and retanoid

  • Signal Transduction
  • Signaling Pathway
  • Nuclear Signaling
  • Nuclear Hormone Receptors
  • Retinoic & Retinoid

  • Epigenetics and Nuclear Signaling
  • Nuclear Signaling Pathways
  • Nuclear Receptors
  • Retinoic & Retinoid

  • Epigenetics and Nuclear Signaling
  • Transcription
  • Domain Families
  • Zinc Finger

Applications

Target

• FunctionReceptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. RARA plays an essential role in the regulation of retinoic acid-induced germ cell development during spermatogenesis. Has a role in the survival of early spermatocytes at the beginning prophase of meiosis. In Sertoli cells, may promote the survival and development of early meiotic prophase spermatocytes. In concert with RARG, required for skeletal growth, matrix homeostasis and growth plate function (By similarity). Regulates expression of target genes in a ligand-dependent manner by recruiting chromatin complexes containing MLL5. Mediates retinoic acid-induced granulopoiesis.
• Involvement in diseaseNote=Chromosomal aberrations involving RARA are commonly found in acute promyelocytic leukemia. Translocation t(11;17)(q32;q21) with ZBTB16/PLZF; translocation t(15;17)(q21;q21) with PML; translocation t(5;17)(q32;q11) with NPM. The PML-RARA oncoprotein requires both the PML ring structure and coiled-coil domain for both interaction with UBE2I, nuclear microspeckle location and sumoylation. In addition, the coiled-coil domain functions in blocking RA-mediated transactivation and cell differentiation.
• Sequence similaritiesBelongs to the nuclear hormone receptor family. NR1 subfamily.
  Contains 1 nuclear receptor DNA-binding domain.
• DomainComposed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain.
• Post-translational
  modificationsPhosphorylated on serine and threonine residues. Phosphorylation does not change during cell cycle. Phosphorylation on Ser-77 is crucial for transcriptional activity (By similarity). Phosphorylation by AKT1 is required for the repressor activity but has no effect on DNA binding, protein stability nor subcellular localization. Phosporylated by PKA in vitro. This phosphorylation on Ser-219 and Ser-369 is critical for ligand binding, nuclear localization and transcriptional activity in response to FSH signaling.
  Sumoylated by SUMO2, mainly on Lys-399 which is also required for SENP6 binding. On all-trans retinoic acid (ATRA) binding, a confromational change may occur that allows sumoylation on two additional site, Lys-166 and Lys-171. Probably desumoylated by SENP6. Sumoylation levels determine nuclear localization and regulate ATRA-mediated transcriptional activity.
  Trimethylation enhances heterodimerization with RXRA and positively modulates the transcriptional activation.
  Ubiquitinated.
• Cellular localizationNucleus. Cytoplasm. Nuclear localization depends on ligand binding, phosphorylation and sumoylation. Transloaction to the nucleus in the absence of ligand is dependent on activation of PKC and the downstream MAPK phosphorylation.

Target information above from: UniProt accession P10276 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010) .

Information by UniProt
• Database links
  • Entrez Gene: 5914 Human
  • Entrez Gene: 19401 Mouse
  • Entrez Gene: 24705 Rat
  • Omim: 180240 Human
  • SwissProt: P10276 Human
  • SwissProt: P11416 Mouse
  • Unigene: 654583 Human
  • Unigene: 439744 Mouse

  • Unigene: 91057 Rat

  see all

• Alternative names
  NR1B1 antibodyNuclear mitotic apparatus protein retinoic acid receptor alpha fusion protein antibodyNuclear receptor subfamily 1 group B member 1 antibody

  Nucleophosmin retinoic acid receptor alpha fusion protein NPM RAR long form antibodyRAR alpha antibodyRAR antibodyRAR-alpha antibodyRARA antibodyRARA_HUMAN antibodyRARalpha antibodyRARalpha1 antibodyRetinoic acid receptor alpha antibodyRetinoic acid receptor alpha polypeptide antibody

  see all

Anti-Retinoic Acid Receptor alpha antibody images

• 

  Western blot - Retinoic Acid Receptor alpha antibody (ab85058)
  Anti-Retinoic Acid Receptor alpha antibody (ab85058) at 1/500 dilution + Human fetal brain lysate
  
  Predicted band size : 51 kDa
  Observed band size : 51 kDa